Expert oncologist Kevin Kalinsky, MD, centers discussion on a patient case of HR+/HER2-low metastatic breast cancer to highlight current treatment options and best practices.
EP. 1: Case Overview: A 65-Year-Old Woman With HR+/HER2-low Metastatic Breast Cancer
Expert oncologist Kevin Kalinsky, MD, reviews the diagnosis and management of a 65-year old woman with HR+/HER2-low metastatic breast cancer.
Watch
EP. 2: HR+/HER2-low Metastatic Breast Cancer: An Evolving Treatment Armamentarium
Comprehensive insight to the treatment armamentarium for patients with HR+/HER2-low metastatic breast cancer and factors that help inform optimal sequencing.
EP. 3: Unmet Needs and Future Directions in HR+/HER2-low Metastatic Breast Cancer
Closing out his review of HR+/HER2-low metastatic breast cancer management, Kevin Kalinsky, MD, considers unmet needs and ongoing investigation into novel treatment strategies.